Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Zhong Ji Longevity Science Group Limited ( (HK:0767) ).
Zhong Ji Longevity Science Group Limited has announced a non-legally binding memorandum of understanding to potentially acquire Asian Integrated Cell Laboratory Limited from China International Osteoarticular Medical Group Limited. This acquisition would enhance Zhong Ji’s capabilities in cell management and transformation, as the target company is a leading platform in the global market, holding the largest international autoimmune cell bank and being the only dual-type full-system clinical cell bank registered by the US FDA in Asia.
More about Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited operates in the biotechnology industry, focusing on health and longevity management services. The company is involved in the research, development, and transformation of cell therapies and drugs.
Average Trading Volume: 1,077,784
Technical Sentiment Signal: Buy
Current Market Cap: HK$305.6M
For detailed information about 0767 stock, go to TipRanks’ Stock Analysis page.